European and USA Pharmaceutical Directory 2024: Indispensable Guide for Key Decision-makers
April 15, 2024 09:04 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "European and USA Pharmaceutical Directory 2024" directory has been added to ResearchAndMarkets.com's offering.The European & USA Pharmaceutical...
Global Directory Unveils Top 1,000 Pharmaceutical and Biotechnology Companies for 2024
April 15, 2024 09:02 ET
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "Major Pharmaceutical Companies 2024" report has been added to ResearchAndMarkets.com's offering. In an era of rapid technological advancements and...
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
April 15, 2024 08:00 ET
|
Optimi Health Corp.
Optimi announces completion of three batches of its MDMA API manufactured from raw materials under the Company’s Precursor Licence.
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mars 2024
April 12, 2024 14:05 ET
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi: Information concerning the total number of voting rights and shares - March 2024
April 12, 2024 14:05 ET
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
Dalrada Financial Corporation Files Patent Application for Proprietary Technology that Creates Carbon Utility Tokens
April 10, 2024 08:45 ET
|
Dalrada Financial Corp.
DFCO stakes its claim in the carbon market with unique software/hardware system that creates a solution for generating, validating, trading carbon tokens
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
April 09, 2024 07:00 ET
|
Agios Pharmaceuticals, Inc.
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report
Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma
April 09, 2024 02:00 ET
|
Essential Pharma
Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma First development-stage asset to be added to the Essential Pharma...
Sanofi - AGM 30.04.2024 - Mise à disposition des documents préparatoires
April 08, 2024 12:00 ET
|
Sanofi - Aventis Groupe
ASSEMBLEE GENERALE MIXTE DU 30 AVRIL 2024 MODALITES DE MISE A DISPOSITION OU DE CONSULTATION DES DOCUMENTS PREPARATOIRES Les actionnaires de la Société sont invités à participer à l’assemblée...
Sanofi - AGM 30.04.2024 - Availability of Preparatory documents
April 08, 2024 12:00 ET
|
Sanofi - Aventis Groupe
COMBINED GENERAL MEETING OF APRIL 30, 2024 AVAILABILITY OF PREPARATORY DOCUMENTS The Company’s shareholders are invited to attend the Combined General Meeting to be held on Thursday April 30, 2024...